2020 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies

2020 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.

Our collection of strategic assessments of leading Generic and Specialty Drug companies provides significant competitor information, analysis and insight critical to the development and implementation of effective business, marketing and R&D programs. The assessments include latest organizational and management developments, acquisitions and divestitures, marketing tactics, financial results, strengths and weaknesses, and strategic directions.

Aurora Cannabis

Canopy Growth

Cronos Group

Curaleaf

Dr. Reddy's Laboratories

Green Thumb

Merck

MomentaPharma

Mylan

Perrigo

Teva Pharma

Tilray

oetis

These reports will complement your internal competitor information gathering efforts with objective strategic analysis, data interpretation and insight.

The reports will also assist current competitors and potential market entrants in evaluating prospective acquisitions and joint venture candidates.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


TOC available on request

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook